Glucokinase Activators for the Potential Treatment of Type 2 Diabetes

E-ISSN： 1873-4294|8|17|1524-1532

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.17, 2008-11, pp. : 1524-1532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Updates on Glucokinase Activators for the Treatment of Type 2 Diabetes Mellitus

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 585-602

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

By Pfefferkorn Jeffrey A

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 319-330

Informa Healthcare

Access to resources Recommend Favorite

Glucokinase activators as new type 2 diabetes therapeutic agents

By Sarabu Ramakanth Berthel Steven J Kester Robert F Tilley Jefferson W

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 759-768

Informa Healthcare

Access to resources Recommend Favorite

Glucokinase activators in diabetes management

By Coghlan Matthew Leighton Brendan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 145-167

Informa Healthcare

Access to resources Recommend Favorite

AMPK Activators as Novel Therapeutics for Type 2 Diabetes

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 4, 2010-03 ,pp. : 397-410

Bentham Science Publishers

Access to resources Recommend Favorite